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PENGESANAN DAN KUANTIFIKASI PERANSANG JENIS 
AMFETAMINA DAN METADON DI DALAM RAMBUT 
MENGGUNAKAN KROMATOGRAFI CECAIR SPEKTROMETRI 
JISIM TRIPLE QUADRUPOLE  (LC QQQ) 
ABSTRAK 
Lebih sedekad yang lalu, analisis rambut dalam penyalah gunaan dadah telah menjadi  
satu alternatif yang penting berbanding ujan dadah di dalam urin. Analisis rambut 
dicadangkan sebagai satu petunjuk yang lebih sesuai dalam ujian pengambilan dadah 
secara kronik kerana dadah terdapat dalam bentuk bebas. Rambut memberi tempoh 
pengesanan yang lebih panjang dan menjadikannya sukar untuk dimanipulasi. Selain itu, 
rambut juga mudah untuk dikumpul dan stabil pada suhu bilik dalam jangka masa yang 
panjang. Analisis rambut semakin meluas digunakan untuk pemeriksaan saringan 
pekerja, bidang sains forensik, kawalan antidoping dan diagnostik klinikal. Oleh kerana 
itu, kajian ini adalah bertujuan untuk membangunkan satu kaedah yang sensitif dan 
khusus untuk mengesan dan menentu-ukur perangsang jenis amfetamina dan metadon 
dalam rambut dan urin, menentukan korelasi penemuan analisis antara urin dan rambut 
dan juga korelasi antara penggunaan metadon dan perangsang jenis amfetamina pada 
penagih. Pembangunan dan validasi kaedah telah dijalankan dengan menggunakan 
kaedah pengekstrakan cecair diikuti dengan Kromatografi Cecair Spektrometri Jisim 
Sejajar (LC/MS/MS). Sampel-sampel diekstrak menggunakan kaedah pengekstrakan 
cecair diikuti hidrolisis menggunakan NaOH dengan kehadiran “deuterated internal 
standards” (d3-metadon,  d3-metamfetamina dan d5-amfetamina). Satu sistem 
LC/MS/MS yang berdasarkan kepada Kromatografi Cecair Spektrometri Jisim Sejajar 
bersama Pengionan Elektrosemburan telah digunakan. Kaedah MS/MS telah 
xix 
 
dioptimuman dengan melakukan pemantauan pelbagai tindak balas. Bagi tujuan 
pengesahan, sebanyak tiga ion diagnostik telah dipantau dan ion yang tertinggi dipilih 
untuk tujuan kuantifikasi dan ion kedua dan ketiga pula digunakan untuk tujuan 
pengesahan. Pengesahan kaedah telah dilakukan mengikut beberapa garis panduan 
daripada piawaian antarabangsa ISO/IEC 17025, WADA ISL dan Nota Teknikal NATA. 
Kaedah pengesahan telah menunjukkan peratus pemulihan adalah lebih daripada 80%. 
Kelinearan diterbitkan pada julat kepekatan 5 – 100 pg/mg rambut dan regresi untuk 
semua analit adalah melebihi 0.997. Had pengesanan ialah 1 pg/mg untuk semua 
sebatian kecuali pada rambut yang dimasukkan metildiamfetamina (MDA) dan 
amfetamina iaitu sebanyak 5 pg/mg. Kejituan intra-hari dan inter-hari adalah kurang 
daripada 10%. Dalam kajian ini, 39 sampel rambut dan urin daripada penagih yang telah 
melalui proses pemulihan telah dianalisis. Kajian telah menunjukkan kepekatan 
metamfetamina, amfetamina dan metadon masing-masing ialah 0.015 - 109.95 ng/mg, 
0.005 - 8.45 ng/mg dan 0.008 - 45.22 ng/mg. Di samping itu, kajian menunjukkan 
bahawa tiada korelasi antara tahap dadah dalam analisis rambut dan urin, seterusnya 
menunjukkan analisis rambut boleh digunakan sebagai penunjuk biologikal yang lebih 
baik kepada penggunaan dadah tunggal, kerap ataupun secara kronik berbanding dengan 
analisis dalam urin. Kesimpulannya, kaedah yang dibangunkan dengan menggunakan 
LC/MS/MS merupakan satu kaedah yang sangat sensitif dan khusus untuk pengesanan 
dan kuantifikasi amfetamina dan metadon. 
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DETECTION AND QUANTIFICATION OF AMPHETAMINE TYPE 
STIMULANTS AND METHADONE IN HAIR USING LIQUID 
CHROMATROGRAPHY TRIPLE QUADRUPOLE (LC QQQ) MASS 
SPECTROMETRY 
ABSTRACT 
 
Over the last decade, analysis of hair for drugs of abuse has emerged as one important 
alternative to urine drug test. Hair analysis has been proposed as a more suitable marker 
of past chronic drug intake as drugs are present in the free form; hair provides a longer 
detection window making it difficult to cheat ; it is easy to collect and the sample is 
stable at room temperature for long period of time . Hair analysis is increasingly used in 
pre-employment and employment screening, in the forensic sciences, doping control and 
clinical diagnostics. Therefore, the aim of this study is to develop a sensitive and 
specific method for the detection and quantification of amphetamine type stimulants 
(ATS) and methadone in hair and urine, establish a correlation between the findings of 
urine and hair analysis in addicts and establish a correlation between the use of 
methadone and ATS in addicts. A method was developed and validated using liquid–
liquid extraction followed by Liquid Chromatography Tandem Mass Spectrometry. The 
samples were extracted using liquid-liquid extraction following hydrolysis with NaOH 
in the presence of deuterated internal standards (d3-methadone,d5-methamphetamine, 
and d5-amphetamine). A bench top LC/MS/MS system based on a Liquid 
Chromatography Triple Quadrupole (LC QQQ) Mass Spectrometry with Electrospray 
ionization (ESI) was used. The optimization of MS/MS method was developed using the 
multiple reaction monitoring (MRM). For the purpose of confirmation, three diagnostic 
xxi 
 
ions were monitored, the most abundant of which was chosen for the purpose of 
quantification and the second two were used for confirmation purposes. Method 
validation was performed according to several guidelines that include the international 
standards ISO/IEC 17025, WADA ISL and NATA Technical Note.  The validated 
method showed that the recoveries were greater than 80%. Linearity was established 
over the concentration range of 5 – 100 pg/mg hair and the regression for the individual 
analytes were all greater than 0.997. The limit of detection (LOD) obtained was 1pg/mg 
for all compounds except for  3,4 methylenedioxyamphetamine (MDA) and 
amphetamine was 5 pg/mg in spiked hair. The intra and inter day precision was 
generally less than 10% in spiked hair. In this study, thirty nine hair and urine samples 
from rehabilitated drug addicts were analyzed. The concentrations of methamphetamine, 
amphetamine and methadone were 0.015 - 109.95 ng/mg, 0.005 - 8.45 ng/mg and 0.008 
-  45.22 ng/mg, respectively. The study showed that there was no correlation between 
drug levels in urine and hair analysis, indicating hair analysis can be used as a better 
biological indicator to prove single use, occasional and chronic drug abuse compared to 
urine. As a conclusion, the developed method using LC/MS/MS was found to be highly 
sensitive and specific for detection and quantification of amphetamines and methadone. 
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1 CHAPTER 1 
INTRODUCTION 
 
1.1 Background and Rationale 
 
Drug abuse has been recognized as a widespread problem around the world. 
Patterns of this problem are constantly changing. They differ significantly on the basis 
of the region, from country to country, and to the geographical areas within the same 
country (Wills, 2005). Since the 1980s, drug abuse has been of a great concern in 
Malaysia and has been identified as one of the major problems that threaten the national 
security (Manaf, 2002).  
 
The severity of drug abuse can be determined from the number of new and 
recurring cases of drug addicts as indicated by the record from the National Narcotics 
Information System (BIONADI) of the National Narcotics Agency of the Ministry of 
Home Affairs, Malaysia. This agency manages the record of all incidences of drug 
addiction cases since 1970 (Manaf, 2002). Statistics of drug addicts detected throughout 
the country for the period from January to December 2010 showed that a total of 23,642 
addicts have been detected; this includes 17,238 new addicts and 6404 relapsed addicts 
representing about 50.24% increase of over the same period the previous year. Also, the 
largest increase was the amphetamine type stimulants amounting 5,001.19% increase 
compared to the previous year (AADK, 2010). Due to the significant increase in drug 
abuse, the state intensified its efforts in increasing awareness and creating a society that 
is free of drugs through adapting the Anti-Drug Education Program at schools, 
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workplace, universities, etc. The Ministry of Education has organized these programs at 
schools through the tools of mass media, seminars, pamphlets, and exhibitions, and 
through promoting healthy outdoor activities and others. However, the Ministry of 
Health is responsible for identifying drug addicts and ensuring the implementation of the 
detoxification programs. All institutions of the state, both governmental and non-
governmental organizations, should contribute to various activities to increase a public 
awareness about drugs.  
 
The use and abuse of illegal drugs affects all modern communities and therefore 
assessment of drug exposure is an important concern that needs to be accomplished. So, 
the detection of drugs of abuse in biological samples is one the primary functions of a 
clinical or forensic toxicology laboratory. Urine testing is most frequently used for 
routine testing for drugs of abuse, but many alternative specimens are establishing their 
place as suitable specimens for drug testing (Khadehjian, 2005). The alternative 
biological matrices include hair, sweat and saliva and have now reached an adequate 
standard of scientific credibility to be considered in federally regulated workplace drug 
testing. The research described in this thesis focuses on the hair analysis for drugs of 
abuse. 
 
Hair analysis is a developing technology that has become both an alternative and 
complementary approach to drug abuse detection. Hair analysis provides some 
advantages over urine analysis. In comparison to urine analysis, the  main advantages of 
hair analysis include (a) it  can be used as a marker of past chronic drug intake by 
providing the retrospective and past periods of drug use that are directly related to the 
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hair length ;(b) long window detection period of abuse ranging from  days to years 
making it difficult to cheat compared to urine or blood (hours to 2-5 days for most 
drugs); (c) the sample collection is non-invasive, it is easy to be performed under 
conditions that prohibit adulteration and substitution (Boumba et al., 2006; Freye & 
Levy, 2009). In recent years, there have been remarkable advances in sensitive and 
specific analytical techniques for determination of drugs in hair samples mainly by Gas 
Chromatography mass Spectrometry (GC/MS) and Liquid Chromatography mass 
Spectrometry (LC/MS). The recent technology of Liquid Chromatography Tandem 
Mass Spectrometry (LC/MS/MS) with sensitivity and specificity allows the detection 
and quantification of many different drugs in biological matrices and often requires less 
sample preparation. According to the review by Maurer LC/MS/MS has the potential to 
become the ‘gold standard’ for forensic and clinical analysis (Maurer, 2005). 
 
Amphetamine Type stimulants (ATS) has been chosen because it represents a 
great public health issue. Recently, the consumption of these drugs has rapidly increased 
among the youth population as recreational drugs (Cirimele, 2006). Methadone has been 
included in this study because its treatment often leads to a decrease in the level of 
primary drug use and reflects the use of stimulants among opiates' users (Gossop et al., 
2000; Peters & Reid, 1998) 
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1.2 Research Objectives 
 
Hair has become the third most popular biological matrix that is used for drug 
analysis after blood and urine. For drugs of abuse, urine and hair are widely accepted as 
forensic evidence because of the non invasive nature in sample collection. Besides, hair 
has a wide diagnostic window of detection at very low levels of drugs. Moreover, the 
ability to establish both chronological profile and severity of drug consumption is 
possible. For hair analysis, a sensitive method is required to ensure the detection at very 
low concentration of drugs. The ability to detect drug at very low concentration 
compared to urine analysis to eliminate false negative. Therefore, this thesis focus on the 
optimization of a single extraction method and faster separation at low detection limit 
with good resolution of analytes. To achieve these goals, the present study is focused on 
the following: 
 
1. Development and optimization of hair analysis using HILIC column. 
2. Development of a sensitive and specific method for the detection and quantification 
of amphetamine type stimulants and methadone in hair using Liquid Chromatography 
Electrospray Ionization (ESI) Tandem Mass Spectrometry. 
3. Establishment of a correlation between drugs concentrations in urine and hair in 
rehabilitated addicts. 
 
  The developed methods will be validated and applied for the detection and 
quantification of amphetamine type stimulants and methadone in hair. 
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1.3 Thesis Layout 
 
The main body of this dissertation consists of a general introduction and 
background, literature reviews, material and methods, results and discussion, 
conclusions as well as recommendations for future study. 
 
CHAPTER ONE is general introduction on the background of drug of abuse, 
testing for drug of abuse and the measurable objectives of this study are briefly 
discussed. 
 
CHAPTER TWO is general literature review which is divided into three major 
parts: (section 1) the hair analysis for drugs of abuse, (section 2) Drug of abuse 
particularly Amphetamine Type Stimulant (ATS) and Methadone, and (section 3) the 
analytical tools for hair analysis. 
 
CHAPTER THREE lists down all the applied materials and methods. The 
method developments involve development and optimization of instrument and 
extraction method included urine and hair analysis. 
 
CHAPTER FOUR presents the results and discussions arising from the study.  
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CHAPTER FIVE is the final chapter which consists of overall conclusions on the 
whole study and recommendations for the future study on hair analysis for drugs of 
abuse. 
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2 CHAPTER 2 
LITERURE REVIEWS 
 
 
This chapter is divided into three sections. Section 2.1 will provide an overview 
of the physiology of hair, mechanisms of drug incorporation into hair, and application of 
hair analysis. Section 2.2 will review the drugs of abuse mainly amphetamine type 
stimulants and methadone, providing an overview of the principles and kinetics of 
absorption, distribution, metabolism and excretion. Finally, section 2.3 will review 
analytical techniques that are used for hair analysis. 
 
2.1 Hair Analysis 
 
Hair analysis for drug of abuse has emerged as both an alternative and 
complementary approach to urine analysis of drug (Boumba et al., 2006; Cooper et al., 
2011; Kintz, 2008; Pragst & Balikova, 2006).  
 
In the 1960s and 1970s, in order to determine the effects of heavy metals, such as 
arsenic, lead, or mercury, hair analysis was employed. As hair could keep substances for 
a prolonged time period, researchers gave a proposition that hair was a suitable 
specimen to blood and urine for evaluating environmental hazards (Boumba et al., 2006; 
Freye & Levy, 2009). As such, the analysis of overall or segmented hairs might facilitate 
objective data on the degree of an individual’s exposure to metals and its capability in 
causing harm. Due to inadequate knowledge on the sensitivity of analytical methods 
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employed for these compounds, the use of hair matrix for organic substances, especially 
pharmaceuticals and drugs of abuse, was examined several years later. In 1979, 
Baumgartner and colleagues published the first report using radioimmunoassay (RIA) to 
detect morphine in the hair of heroin abusers (Baumgartner et al., 1979). Since then, a 
number of drugs including amphetamines, cocaine, cannabinoids and phencyclidine 
have been reported to be incorporated in hair. In addition, fetal hair has been used to 
detect maternal drug abuse during pregnancy. Technically, in comparison to testing 
many other matrices, testing of hair for drugs is less tedious. More so, in spite of the 
initial sample preparation, the application of analytical methods and instrumental 
approaches in several cases is quite similar (Kintz, 2008). The Society of Hair Testing 
(SoHT) founded in 1995. The goals of SoHT are (a) promotion of research in hair 
testing technologies in forensic, clinical and occupational sciences, (b) development of 
international proficiency tests, (c) organization of meetings and workshops and (d) 
encouragement to scientific cooperation and exchanges among members (Jurado & 
Sachs, 2003; SoHT, 2004; Pragst & Balikova, 2006). The guidelines of SoHT provide 
recommended best practice guidelines whether laboratories are planning or currently 
offering drugs testing in hair. These guidelines include reference to recommended 
sample collection and storage procedures, through sample preparation, pre-treatment, 
analysis, and the use of cut-offs (Cooper et al., 2011; SoHT, 1997).   
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2.1.1 Hair Physiology 
 
2.1.1.1  Structure of Human Hair 
 
Hair is a filamentous biomaterial which evolves from the hair follicle found on 
the dermis; it is a product of differentiated organs in the skin of mammals. Chemical 
composition of hair is 65 to 95% protein, 1 to 9% lipids, 0.1 to 5% pigments (melanin) 
and minute amounts of trace elements, polysaccharides and water (Harkey, 1993; 
Robbins, 2002). 
 
Every hair shaft is composed of three unique types of cells: an outer cuticle, 
which encloses a central cortex which may further consist of a central medulla. The 
cuticle consists of overlapping scale cells that help guide the hair shaft in the follicle and 
defend the interior fibers. The cortex is composed of spindle-shaped cortical cells and in 
the core of the cortex there may be condensed cells forming the medulla, which might be 
continuous or diversified with air spaces. The type of pigment and alignment gives hair 
its color while pigment granules are also found in cortical cells. For more illustration on 
the structure of hair follicle, consider Figure 2.1 below. 
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Figure 2.1 Simplified diagram of hair structure (Boumba et al., 2006) 
 
2.1.1.2 The Growth of Human Hair 
 
The growth of human hair relies on several factors such as diet, health, inherited 
traits, hormone balance, age, physical condition, climate, chemical effects, sex, and the 
presence of any disease. Switching between the periods of growth (anagen phase) and 
the periods of quiescence (catagen and telogen phases), the hair shaft begins in a follicle 
closely connected with glands (sebaceous and apocrine) and grows in cycles (Harkey, 
1993; Kronstrand & Scott, 2006). 
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Figure 2.2 The hair growth cycle (One, 2010 ) 
 
Anagen is defined as the growth period when the follicle mature and hair 
develop. Generally, the period of anagen phase varies between 7 to 94 weeks but, may 
also eventually last for many years, depending on the anatomical region (Harkey, 1993). 
In the case of head hair, it can grow for a period of 4 to 8 years (< 12 months for non-
head hair) at a rate proportional to 0.22 to 0.52 mm/day or 0.6 to 1.42 cm/month                     
(Castanet & Ortonne, 1997).    
 
Anagen is followed by Catagen, which is the phase of regression. Cell division 
stops during this phase, and the changes leads to the base of the hair shaft becoming 
fully keratinized forming dry, white node characteristic of a ‘club’ hair.  It takes 2 weeks 
for the formation of the follicle bulb, following which it will start to begin degenerate 
(Harkey, 1993). 
 
 Catagen is followed by telogen phase, which is the phase of resting or quiescent 
period. The growth of the hair shaft totally stops during this phase and remains in the 
upper portion of the follicular canal whereby it can be easily dislodged by pulling. The 
duration of this phase increases gradually with age and depends on the body area where 
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hair is found. In terms of the scalp hair, the resting phase is about 10 weeks which is 
comparably short and is about 2-6 years for the general body surface. Another growth 
cycle starts after the telogen phase (Harkey, 1993). 
 
2.1.1.3 Pigmentation 
 
In mammals, melanin is formed in specialized cells called melanocytes, which 
covers distinct cytoplasmic organelles known as melanosomes. Four stages are involved 
in Pigment formation (follicular melanogenesis) in the melanosomes (Robbins, 2002). In 
the first stage, tyrosinase and protein constitute the basic structural unit, in the next stage 
an inner membranous structure is formed wherein the melanin is biosynthesized and 
accumulated. At the final stage, the melanosome changes into a uniformly dense 
melanin particle. The pigmented hair shaft is formed when the melanized melanosomes 
is transferred into cortical and medulla keratinocytes. During the anagenic stage of the 
hair growth cycle, this activity is regulated by a number of enzymes, structural and 
regulatory proteins, transporters, receptors and their ligands (Slominski et al., 2004). 
 
2.1.2 Drug Incorporation Routes 
 
There have been several studies on the paths for drug incorporation into hair: 
from the bloodstream, from sweat and other secretions, and from external 
contamination. Figure 2.3 shows the model of drug incorporation into hair. 
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Figure 2.3 The models of drug incorporation in hair (Pragst & Balikova, 2006) 
 
2.1.2.1  Incorporation from the Bloodstream 
 
The passive transfer is the simplest model which describes drug incorporation 
into hair from the bloodstream (Boumba et al., 2006; Pragst & Balikova, 2006). In this 
model, the hair follicle is provided with a sufficient blood supply, due to rapid cell 
division in the cells forming hair. Therefore, the drugs circulating in the blood will also 
reach the hair follicle. Firstly, a drug has to diffuse across the cell membrane to enter the 
matrix cells of the growing hair. The rate of this transport, where only drug molecules 
which are not bound to protein may be involved and this is further affected by the lipid 
solubility of the drug. In addition, the pH gradient between the plasma and the cell is 
critical for the transport (Kronstrand & Scott, 2006). Many drugs vary between either 
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weak bases or weak acids that can be protonated or deprotonated. The pH of plasma is 
7.3, whereas the pH of the keratinocytes and melanocytes is lower, varying between 3 
and 6 (Robbins, 2002). 
 
2.1.2.2  Incorporation from Sweat and Other Secretions 
 
There are several studies which support the evidence of incorporation of drugs 
from sweat and other secretion into hair. Amphetamine (Vree et al., 1972), heroin, 
cocaine and metabolites (Cone et al., 1994) and methadone (Henderson & Wilson, 1973) 
have been found in sweat, often in concentrations greater than blood.  It is a fact that the 
drugs and metabolites are excreted in sweat. Hair is porous, and therefore absorbs liquid 
resulting in an increase in weight of up to 18% and due to this property; drugs may be 
transferred easily to hair through sweat. According to Henderson et al. (1996) in a study 
that examines the dose response relationships of deuterated cocaine into hair, it was 
found that deuterated cocaine was detected in multiple segments after single dose, 
upholding sweat or other secretions as a path for drug deposition in hair. 
 
2.1.2.3 Incorporation from External Contamination 
 
Environmental exposure (air, water, smoking or hair treatment) to drugs may 
contaminate hair specimens and drug users often defend positive hair testing results by 
claiming passive exposure to drugs. Before extraction of drugs, decontamination of hair 
specimens is very important because it removes any external contamination and is 
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essential to produce valid results. Joya, et al. (2009) reported that unsuspected exposure 
of cocaine in preschool children between 18 months and 5 years old using hair analysis 
and found 88% of positive cases for cocaine were also found in the hair of 
accompanying parents. This reflects the passive exposure to drugs. In another study, 
Garcia et al. (2009) observed that measurement of cocaine hair concentrations can allow 
estimation of the degree environmental drug exposure in young children. Koren et al. 
(1992) showed that pyrolysis of crack results in accumulation of cocaine in hair, but not 
its metabolite benzoylecgonine. In cocaine abusers, both cocaine and benzoylecgonine 
are detectable in hair. Washing may not remove all cocaine in hair accumulated from 
extensive environmental exposure. On the other hand, if intense washing procedures are 
used, they can lead to removal of drugs from hair, thus raising the chance of false 
negative results (Paulsen et al., 2001; Romano et al., 2001).  
 
2.1.3 Factor Affecting the Content of Drugs on Hair 
 
2.1.3.1  Effects of Hair Color 
 
Melanin that determines hair colour is a polyanionic polymer of eumelanin and 
pheomelanin. Eumelanin concentration is highest in black colored hair whereas red hair 
has the highest concentration of pheomelanin. White hairs do not have melanin. It has 
been hypothesized that incorporation of various drugs into hair depends on the 
concentration of melanin. However, there are conflicting reports in the literature as to 
whether there is any significant difference between hair color as well as ethnicity and 
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incorporation of drugs into hair. Kronstrand et al. (2003) measured methamphetamine 
and amphetamine levels in patients receiving selegiline, the drug which metabolizes to 
methamphetamine and amphetamine. Methamphetamine and amphetamine in hair 
showed preference for pigmented hairs over white hair. Goldberger et al. (1998) found 
higher concentrations of cocaine in hair of people of African origin compared to the 
Caucasoid group. In contrast, Schaffer et al. (2005) studied cocaine incorporation in 
blonde, auburn, brown and black hair, and did not observe any difference between hair 
specimens of different colors. However, when hair was permed, there was an increase in 
cocaine uptake. A study on 1,852 applicants for employment that classified them as 
“black” or “white” showed no significant difference between hair and urine drug test 
results for these two classes (Hoffman, 1999). 
 
2.1.3.2 Effects of Cosmetic Treatments 
 
Significant concerns with regard to drug analysis in hair are the change in the 
concentration of drug-induced effects of the cosmetic treatment of hair.  This treatment 
has strong chemical, physical and mechanical influence could have harmful effects on 
the cuticle: this includes perming, straightening, dyeing, bleaching, excessive washing, 
intensive illumination with ultraviolet radiation, excessive exposure to sunlight (Agius & 
Kintz, 2010; Panagotacos, 2005). Jurado et al. (1997) investigated the effects of 
cosmetic treatment (bleaching and dyeing) among cannabis and nicotine concentration 
in hair. Their findings support the hypothesis that the cosmetic treatment of hair 
17 
 
decreases concentrations of drug in all treated hair samples especially in cases of 
severely damaged hair. 
2.1.4 Adulteration of Hair Specimens 
 
 Under direct supervision, the chances of adulteration during sample collection 
are low. The treatment of hair before sample collection can occur and may affect the 
results. There are a number of products available on the Internet which guarantees a 
negative drug test in hair. Rohrich et al. (2000) studied the effect of Ultra Clean on 
removing tetrahydrocannabinol (THC), codeine, morphine, cocaine, amphetamine,                                   
3,4-ethylenedioxyamphetamine(MDA), heroin, 6-monoacetylmorphine (6-MAM),         
3,4-methylenedioxymethamphetamine(MDMA), 3,4-methylenedioxyethylamphetamine 
(MDE), dihydrocodeine and methadone from postmortem hair samples with known 
histories of drug abuse. The authors found that none of the specimens tested negative 
after treatment with shampoo and there was only a slight decrease in drug concentrations 
compared to untreated specimens. The results showed that drug substances had not been 
sufficiently eliminated from human hair by single ultra clean treatment to cause negative 
results (Dasgupta, 2010a). 
 
2.1.5 Collection Procedures  
 
Collection procedures for hair analysis for drugs have not been properly arranged 
(Kintz, 2008). Among the widely published studies, the samples are acquired from 
random locations on the scalp, albeit, hair is picked suitably from the back of the head. 
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This is called the vertex posterior which is the best collection site. In comparison with 
other areas of the head, this area has lesser variation in the hair growth rate at 
approximately 85% (Kronstrand & Druid, 2006). The number of hair strands during the 
growing phase is more stable, and also less influenced by factors of age- and sex-related 
parameter.  After collection, hair samples should be wrapped in aluminum foil to 
preserve the alignment, and root and tips ends must be distinguished. Depending on the 
drug to be analyzed and the test methodology, sample size varies significantly within 
laboratories and relies on the sample sizes highlighted in the literature; this  range from a 
single hair to 200 mg (Kintz, 2008). When sectional analysis is conducted, the hair is cut 
into segments of about 1, 2, or 3 cm, which correlates roughly to about 1, 2, or 3 
months’ growth. When scalp hair is not available, other types of hair (pubic hair, arm 
hair, or axillary hair) can be collected as an optional source for drug detection. 
 
2.1.6  Methodology of Hair Analysis 
 
Hair analysis involves at least five steps: (a)decontamination of the hair,(b) 
preparation of hair: pulverization, segmentation in short pieces,(c) incubation in 
methanol, acid, sodium hydroxide, buffer,(d) extraction : liquid-liquid extraction (LLE), 
solid phase extraction (SPE), solid phase microextraction (SPME), and (e) analysis: 
immunoassay, screening or/and chromatography coupled to mass spectrometry (Boumba 
et al., 2006; Pragst & Balikova, 2006; Srogi, 2006).  
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2.1.7 Applications of Hair Analysis 
 
The applications of hair analysis are widely used in clinical applications, 
criminal investigations (drug-related deaths, drug-facilitated crime, child protection, 
etc.), for monitoring drug misuse such as drug rehabilitation programs, workplace, drug 
testing and driving license re-granting. The clinical applications of hair analysis include 
psychiatric patients, epileptic management and therapeutic drug monitoring (Cooper et 
al., 2011; Pragst & Balikova, 2006).  
 
2.2 Drugs of Abuse 
 
Drug abuse remains a significant public health issue worldwide. It refers to the 
use of harmful or dangerous psychotropic substances, including alcohol and illicit drugs. 
The use of psychotropic substances leads to a dependency syndrome. This syndrome is 
defined as a group of behavioral and cognitive physiological phenomena, which arise 
after the repeated use of the material.   Using such drugs leads to have a strong desire to 
keep taking them, have difficulties in controlling their use despite their harmful effects. 
Patterns of drug abuse in all parts of the world are constantly changing. They differ 
significantly on the basis of the region, from country to country, and to the geographical 
area within the same country. For example, widespread methamphetamine abuse is 
causing concern in the United States, Australia and Southeast Asia, but has less 
influence in northern Europe (Wills, 2005). 
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2.2.1 Amphetamine Type Stimulants 
 
After cannabinoids (Marijuana), amphetamines and designer drugs (Ecstasy) 
are the most consumed drugs. So, there has been great concern about the use of 
amphetamine type stimulants (ATS) as a public health issue.  In recent years, the 
consumption of these drugs increased rapidly among the youth population as 
recreational drugs (Cirimele, 2006). Abuse of the powerful psychostimulants, 
amphetamine and methamphetamine is widespread in some geographical regions such as 
United States, Far East, Japan, with increasing consumption of designer drugs 
amphetamines being observed in European countries (Cirimele, 2006). 
 
Amphetamines are Central Nervous Stimulant (CNS) and powerful synthetic 
psychostimulant drugs which increase the levels of norepinephrine, serotonin, and 
dopamine in the brain inducing emotion. Amphetamine-type stimulants (ATS) are 
collectively referred to several stimulants and hallucinogens chemically related to 
phenylethylamine (Dasgupta, 2010b). 
 
Amphetamines are sympathomimetic amines that are often optically active. 
Amphetamine and any related designer are weak bases with low molecular weight that 
allows them to diffuse across membranes before being incorporated with 
nonconventional biological matrices, such as hair or nail. It has been noticed that using 
blood or urine for the purpose of measuring the level of drugs helps reflect a period of 
exposure that is over several hours or days before sampling. On the other hand, using 
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hair for drug detection allows the past medication history and drug abuse of an 
individual (Cirimele, 2006). 
 
Amphetamine type stimulants (ATS) include amphetamine itself, 
dexamphetamine, methamphetamine, and fenfluramine. In addition to the 
amphetamines, there are other related compounds, such as methylphenidate, 
methylenedioxymethamphetamine (MDMA) and methylenedioxyamphetamine (MDA, 
or love pills). The focus of the present research is on a particular amphetamine, 
methamphetamine, MDA and MDMA. Figure 2.4 below illustrates the chemical 
structures of ATS. 
 
22 
 
NH2
CH3
(R)-1-phenylpropan-2-amine
Chemical Formula: C9H13N
L-amphetamine
NH2
(S)-1-phenylpropan-2-amine
Chemical Formula: C9H13N
D-methamphetamine
D-amphetamine
O
O
NH2
CH3
1-(benzo[d][1,3]dioxol-5-yl)propan-2-amine
Chemical Formula: C10H13NO2
MDA
O
O
NH
CH3
CH3
MDMA
1-(benzo[d][1,3]dioxol-5-yl)-N -methylpropan-2-amine
Chemical Formula: C11H15NO2
L-methamphetamine
N
CH3
H
H3C H
(S)-N -methyl-1-phenylpropan-2-amine
Chemical Formula: C10H15N
N
H3C
H
(R)-N -methyl-1-phenylpropan-2-amine
Chemical Formula: C10H15N
CH3H
 
 
Figure 2.4 Chemical structures of amphetamine type stimulants (Freye & Levy, 2009; 
Wada et al., 2010) 
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2.2.1.1 Physiochemical Properties  
 
Both amphetamine and methamphetamine are chiral compounds. The racemic 
mixture can be divided into their optical isomers: levo (l) and dextro (d) isomeric forms. 
The d-amphetamine form has significant stimulant activity, and possesses approximately 
3 to 4 times the central activity of the l-form. It is also important to note that the d- and l-
enantiomers may not only have different pharmacological activity but also varying 
pharmacokinetic characteristics (Wills, 2005). The d-methamphetamine has significant 
central stimulant activity than the l-form and is commonly abused. However, l-
methamphetamine has significant peripheral sympathomimethic activity and is typically 
found in non-prescription inhalers such as a decongestant. Because the free 
amphetamine and methampetamine molecules are rather insoluble oily liquid, they are 
usually handled as salts, such as methamphetamine hydrochloride. The salts are 
dissociated in the body, liberating the free amine to cause the known sympathomimetic 
effects (Freye & Levy, 2009). 
 
3, 4-methylenedioxymethamphetamine (MDMA, ecstasy) is a ring substituted 
derivative of methamphetamine and one of the most abused designer drugs. This drug 
was synthesized by a chemist at Merck in 1914 as an appetite suppressant (Freye & 
Levy, 2009; Jenkins, 2006).  
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Another closely related designer drug, 3, 4-methylenedioxyamphetamine (MDA) 
is a potent psychotropic amphetamine derivative which was first synthesized in 1910.  
After 1986, a large number of amphetamine analogs were synthesized by clandestine 
laboratories to produce more potent effects after abuse (Jenkins, 2006). Table 2.1 shows 
the summary of physiochemical properties of Amphetamine Type stimulant (ATS). 
 
2.2.1.2 Absorption 
 
There is limited data is available on the gastrointestinal absorption of 
amphetamine in humans. Beckett and Rowland (1965) investigated serum 
concentrations of amphetamine in two healthy volunteers after a 15 mg oral dose of the 
d-isomer. He found that peak serum concentrations (48 and 40 ng/mL) were observed at 
1.25h in acidic urine. Slightly higher serum concentrations were achieved (52 and 47 
ng/mL) if the urine pH conditions were not controlled. 
 
Absorption of methamphetamine by the oral route, dose of 5 to 10 mg typically 
result in blood concentrations of between 20 to 60 ng/mL (Jenkins, 2006). Peak 
methamphetamine concentrations occur at 3.6 h with a mean concentration of  20ng/mL 
after oral administered of a single dose of 0.125 mg/kg methamphetamine (Baselt & 
Cravey, 1995). 
